Skip to main content
logo
Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,250
+950 (2.94%)
At close: Aug 24, 2026

Next Biomedical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
267,356733,427331,554---
Market Cap Growth
-40.94%121.21%----
Enterprise Value
239,318714,251316,300---
Last Close Price
32300.0089400.0041000.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1149.61-115.95---
PS Ratio
15.0344.5134.74---
PB Ratio
5.4415.257.34---
P/TBV Ratio
5.4815.357.39---
P/OCF Ratio
317.36586.68----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.4543.3533.15---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.140.160.240.700.566.25
Net Debt / Equity Ratio
-0.57-0.61-0.68-0.17-0.191.92
Net Debt / EBITDA Ratio
15.90145.679.950.580.71-1.49
Net Debt / FCF Ratio
155.6515.4018.700.660.45-1.60
Asset Turnover
0.290.280.220.160.080.07
Inventory Turnover
1.901.791.601.371.611.83
Quick Ratio
4.464.893.681.351.381.70
Current Ratio
5.025.383.951.571.591.82
Return on Equity (ROE)
0.49%-0.67%9.28%-41.64%-46.30%-
Return on Assets (ROA)
-2.33%-0.76%-5.05%-10.57%-10.03%-13.55%
Return on Capital Employed (ROCE)
-4.20%-1.40%-7.60%-28.70%-27.30%-26.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.09%-0.04%0.86%---
FCF Yield
-0.07%-0.26%-0.50%---
Buyback Yield / Dilution
-2.72%-12.84%-14.72%-1.10%-28.34%-13.05%